The character of inhibition of the metabolism of 1,2-benzopyrone (coumarin) by grapefruit juice in human (original) (raw)

Abstract

Objective: Constituents of grapefruit juice are known to interfere with mammalian cytochrome P450 isozymes such as intestinal CYP3A4 and hepatic CYP2A6, lowering the biotransformation of drugs and increasing their bioavailability. The aim of this study was to investigate whether the presence of naringin is demanded for the inhibition of the coumarin 7-hydroxylase in man or other compounds are responsible for it.

Methods: In cross-over studies, doses of 10 mg coumarin, together with combinations of grapefruit juice, water and naringin, were given orally to one healthy male volunteer. We investigated increasing amounts of grape-fruit juice, keeping the volume of liquid constant at 1 L; increasing doses of naringin given in water; increasing amounts of juice, keeping the dose of naringin constant; or increasing doses of naringin, keeping the amount of juice constant. Urine samples were collected up to 24 h after dosing and 7-hydroxycoumarin was quantified fluorimetrically in urine hydrolysates after HPLC separation to determine the excretion rates.

Results: While increasing amounts of grapefruit juice delay the excretion of 7-hydroxycoumarin by 2 h, increasing doses of naringin in water up to twofold (i.e. naringin content of 2 L grapefruit juice) do not cause any alteration in the time course of excretion. Experiments with increasing amounts of juice, keeping the dose of naringin constant, indicate that the inhibitory potency of small amounts of grapefruit juice can be amplified by naringin. The same is true when the ratio between juice constituents and naringin is enhanced up to threefold by adding naringin.

Conclusion: As naringin alone is ineffective, the inhibitory effect of grapefruit juice on the metabolism of coumarin is caused by at least one compound other than naringin. The persistency of the primary inhibitor not identified yet can obviously be modulated by the naring(en)in-system.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Toxicology and Pharmacology, Philipps-University, Karl-von-Frisch-Strasse, D-35 033 Marburg, Germany Fax +49 6421 28 2291; e-mail: legrum@mailer.uni-marburg.de, , , , , , DE
    M. Runkel, M. Bourian & W. Legrum
  2. Department of Pharmaceutical Technology and Biopharmacy, Schaper & Brümmer, GmbH & Co KG, Bahnhofstrasse 35, D-35 259 Salzgitter, Germany, , , , , , DE
    M. Tegtmeier

Authors

  1. M. Runkel
    You can also search for this author inPubMed Google Scholar
  2. M. Bourian
    You can also search for this author inPubMed Google Scholar
  3. M. Tegtmeier
    You can also search for this author inPubMed Google Scholar
  4. W. Legrum
    You can also search for this author inPubMed Google Scholar

Additional information

Received: 17 February 1997 / Accepted in revised form: 10 June 1997

Rights and permissions

About this article

Cite this article

Runkel, M., Bourian, M., Tegtmeier, M. et al. The character of inhibition of the metabolism of 1,2-benzopyrone (coumarin) by grapefruit juice in human.E J Clin Pharmacol 53, 265–269 (1997). https://doi.org/10.1007/s002280050374

Download citation